跳至主要内容

Caco-2 Cell Permeability Assay

 Caco-2 cell

Caco-2 cells are human colon cancer cell line commonly used to simulate the characteristics and functions of the epithelial cell layer of the human small intestine. This cell line was first isolated from a tumor in a male patient with colon adenocarcinoma in 1977 and was named Caco-2.

Caco-2 Permeability Assay is a commonly used in vitro experimental method to evaluate the absorption and permeability of compounds in the human intestinal tract. The absorption and permeability of drugs are important pharmacokinetic parameters when administered orally. Based on the characteristics of the human colon cancer cell line Caco-2, it is possible to predict the oral bioavailability of compounds by simulating the conditions of the small intestinal epithelial cell layer. When Caco-2 cells are cultured on permeable polycarbonate membranes, they form a monolayer of epithelial cells that can simulate the morphology of human intestinal epithelial cells, with apical (AP) and basolateral (BL) structures and brush border microvilli on the apical surface. Compared to Parallel Artificial Membrane Permeability Assay (PAMPA), Caco-2 cells have lower flux and higher cost. However, Caco-2 cells can simultaneously screen large quantities of drugs quickly with less drug required, making them a relatively economical and time-saving choice compared to animal models. Furthermore, Caco-2 cells can express intestinal transporters and enzymes, making it possible to predict active transport and drug interactions involving multiple transporters.

The steps of Caco-2 cell permeability assays are as follows:

  • Pre-culture Caco-2 cells on porous transparent culture membranes to form a monolayer of cells, usually taking 14-28 days. During the culture process, ensure that Caco-2 cells reach a certain level of differentiation to better simulate the intestinal epithelial cell layer.
  • Add the test compounds to HBSS and allow it to come into contact with the Caco-2 cells.
  • Incubate the cells in a CO2 incubator at a constant temperature, humidity, and CO2 concentration for a certain period of time, usually taking 2 hours.
  • After incubation, collect the upper (above the cells) and lower (below the cell layer into the porous membrane) compartments separately.
  • Measure the concentration of the compounds in the samples using appropriate techniques such as High-Performance Liquid Chromatography (HPLC) or Liquid Chromatography-Mass Spectrometry (LC-MS).
  • Calculate the compound’s permeability rate, absorption rate, and other relevant parameters by comparing the compound’s concentration in the upper and lower compartments. The calculation of the apparent permeability coefficient (Papp) of the drug in the Caco-2 cell monolayer model is Papp＝ dCr／dt ×Vr× １／A × １／C０ ,the unit of Papp is cm/s.
In Vitro Pharmacokinetic Assays

Medicilon has rich experience in in vitro research on pharmacokinetics including metabolic stability, P450 induction and inhibition, metabolic pathway and metabolite identification, with animals involved including rats, mice, rabbits, dogs and monkeys. For more.

Medicilon has over 19 years of experience in in vitro pharmacokinetic studies and can provide various in vitro research services, including metabolic stability, P450 induction and inhibition, metabolic pathway studies, and metabolite identification. The animals involved in the studies include rats, mice, rabbits, dogs, monkeys, etc. Medicilon completes over 20 preclinical DMPK declaration studies for new drugs each year and conducts PK screening of more than 2000 compounds annually. As a one-step integrated service platform, Medicilon is committed to exploring advanced technologies and methods to meet the needs of customers in exploring new drug development and providing more efficient and cost-effective research services to accelerate the drug development process. Empowering global partners, focusing on Chinese innovation, and contributing to human health!

Reference;

  1. Xiu-wei Yang, Xiao-da Yang, Ying Wang, Lian Ma, Yue Zhang, Xiao-gai Yang, Kui Wang. Establishment of Caco-2 cell monolayer model and standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2007, 5(6): 634-641.
  2. Wang Sha,Liu Siqi,Ding Pengmin,Pang Yuesheng,Tao Zhi,Wang Rufeng (2020). Application of in vitro Models in Metabolism of Traditional Chinese Medicines.PROGRESS IN PHARMACEUTICAL SCIENCES,44(2), 119-132.
标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Enzyme Activity Assay Service

  Enzymatic assay Lance Assay Alphascreen Assay Z’-LYTE Assay Adapta Assay Kinase-Glo Assay ADP-Glo Assay Ligand Binding Assay ELISA Assay HTRF Assay Enzyme activity assays  are laboratory methods for measuring enzymatic activity. They are vital for the study of enzyme kinetics and enzyme inhibition. Enzyme units : Amounts of enzymes can either be expressed as molar amounts, as with any other chemical, or measured in terms of activity, in enzyme units. Medicilon provides various  enzyme activity assays  for  kinases , phosphatases, proteinases, deacetylase, peptidase, esterase, and other enzymes. Our line of well-characterized immunoassays and biochemical kits ensures accurate and reproducible results. Enzyme is a  large category of bio-molecules  that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high sp
发表评论
阅读全文